Long-Term Tolerability of Antifibrotic Therapy for the Patients with Pulmonary Fibrosis After Acute Exacerbation

被引：0
|
作者：
Tateishi, T. [1 ]
Okamoto, T. [1 ]
Miyazaki, Y. [1 ]
机构：
[1] Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1498
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC SIGNIFICANCE OF ANTIFIBROTIC AGENTS IN IDIOPATHIC PULMONARY FIBROSIS AFTER INITIATION OF LONG-TERM OXYGEN THERAPY
    Ishiwari, Mayuko
    Kono, Yuta
    Togashi, Yuki
    Kobayashi, Kenichi
    Kikuchi, Ryota
    Kogami, Mariko
    Abe, Shinji
    [J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (01)
  • [2] Efficacy of Antifibrotic Treatments for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
    Sugino, K.
    Ono, H.
    Watanabe, N.
    Ando, M.
    Tsuboi, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Long-term tolerability of real-life use of antifibrotic agents (AFA) in Idiopathic Pulmonary Fibrosis (IPF)
    Strens, Danielle
    Bondue, Benjamin
    Dahlqvist, Caroline
    Slabbynck, Hans
    Guiot, Julien
    Joos, Guy
    Gusbin, Natacha
    Wirtz, Gil
    Froidure, Antoine
    Wuyts, Wim
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [4] INTERSTITIAL PULMONARY FIBROSIS AFTER LONG-TERM BUSULFAN THERAPY
    BOYLES, PW
    [J]. CLINICAL MEDICINE, 1969, 76 (06): : 11 - &
  • [5] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Tomos, Ioannis
    Dimakopoulou, Konstantina
    Manali, Effrosyni D.
    Papiris, Spyros A.
    Karakatsani, Anna
    [J]. ENVIRONMENTAL HEALTH, 2021, 20 (01)
  • [6] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Ioannis Tomos
    Konstantina Dimakopoulou
    Effrosyni D. Manali
    Spyros A. Papiris
    Anna Karakatsani
    [J]. Environmental Health, 20
  • [7] Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience
    Nayci, Sibel
    Polat, Demet
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [8] Long-Term Personal Exposure to Air Pollution and Risk for Acute Exacerbation of Idiopathic Pulmonary Fibrosis, in Greece
    Tomos, I.
    Dimakopoulou, K.
    Manali, E.
    Karakatsani, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis
    Heltshe, Sonya L.
    Goss, Christopher H.
    Thompson, Valeria
    Sagel, Scott D.
    Sanders, Don B.
    Marshall, Bruce C.
    Flume, Patrick A.
    [J]. THORAX, 2016, 71 (03) : 223 - 229
  • [10] The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry
    Lee, Cathryn T.
    Hao, Wei
    Burg, Cindy A.
    Best, Jennie
    Kolenic, Giselle E.
    Strek, Mary E.
    [J]. RESPIRATORY RESEARCH, 2024, 25 (01)
12345